About Stryker Corp
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.stryker.com/
Frequently Asked Questions
What is the 52-week range for SYK?
The 52-week high is $392.55 and the 52-week low is $267.
What is the P/E ratio for SYK?
The Price to Earnings (P/E) ratio is 28.33.
What is the dividend yield for SYK?
The indicated annual dividend yield is 1.02%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 16.36%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 14.43%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 6.00.
Analyst Recommendation Trends
Wall Street analyst consensus for SYK over the last few months:
Latest SYK News
3 AI Healthcare Stocks With Earnings Growth Up To 15%
Runaway demand for AI data centers, highlighted by Nvidia’s US$5.7t market cap milestone, shows how quickly capital is chasing tools that can crunch medical data, scan images, and support virtual care at global scale. That same engine is starting to reshape healthcare. Missing the early phase may mean missing where a lot of value could potentially accrue. This article breaks down three AI healthcare stocks from the screener that are worth watching. The three stocks covered below are only a...
GEHC vs. SYK: Which Stock Should Value Investors Buy Now?
GEHC vs. SYK: Which Stock Is the Better Value Option?
Are You Overpaying For Intuitive Surgical Stock Versus Its Rivals?
Intuitive Surgical (ISRG) grows faster and earns a higher operating margin than any of the five rivals in its health care peer group. It is also the most expensive of the six when price is measured against earnings. It holds that place even after its stock fell 10.3% over the past twelve months. How much more do you pay for a dollar of Intuitive's earnings than for a dollar of a rival's.
The Top HealthTech Questions Landing On Our Desks
Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation.
Stifel Maintains Buy on Stryker, Lowers Price Target to $330
Stifel analyst Rick Wise maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $360 to $330.
Do You Really Understand ISRG Stock's Risk?
Look at the breakdown of Intuitive Surgical's revenue streams—Instruments and Accessories alone generate roughly 60% of the top line on a per-procedure basis. That tight link between surgery volume and cash flow explains why investors reacted so sharply when Intuitive noted in its fiscal Q2 2026 call that U.S. procedure growth had slowed. With recurring earnings visibility clouded, how much downside risk is the market actually pricing in.
Boston Scientific: Market Pessimism Has Pushed The Stock Into Undervalued Territory
Boston Scientific shares slumped 55% over 12 months, driven by weakness in electrophysiology and WATCHMAN. Learn why BSX stock is a buy.
How Big Could BSX Stock's Next Fall Be?
Boston Scientific (BSX) stock has lost more than half its value over the past 12 months, while the S&P 500 returned 18.0%. A subsequent setback occurred in September, when the company said a cyberattack would likely keep it from meeting its guidance. If the wider market turns now, how big could the next fall be, and how long would you wait? The answer depends on how well Boston Scientific is equipped to absorb a broader downturn today.
Is ResMed A Better Way Than Stryker To Own Medical Device Growth?
Stryker's sales have grown about 10% a year on average over the past three years, and so have ResMed's. That shared growth rate in medical devices is the bet the two have in common. Stryker (SYK) is the giant, selling hospitals everything from hip and knee products to capital equipment. ResMed is a sleep device maker with less than a quarter of Stryker's revenue. Stryker costs 32.6 times its past year's earnings, against 21.9 times for ResMed. So does Stryker's reach justify that higher price? T
An Investor's Guide To Switching Costs
Switching costs provide a company with the leverage to increase prices and deliver hefty profits over time. Read more here.
Dividend Champion, Contender, And Challenger Highlights: Week September 27
Get the weekly summary of dividend changes for Dividend Champions, Contenders & Challengers, plus upcoming ex-dividend and pay dates.
ELFA Names James Cress Acting President & CEO
WASHINGTON, Sept. 25, 2026 (GLOBE NEWSWIRE) -- The Equipment Leasing & Finance Association (ELFA) announced that its Board of Directors has selected James Cress, ELFA’s Immediate Past Chair, to serve as Acting President & CEO while the Association searches for its next permanent President & CEO. This decision follows ELFA’s earlier announcement that President & CEO Leigh Lytle would conclude her tenure with the Association later this year. “I am so pleased that James has agreed to serve as Actin
Can This Number Push ISRG Stock Higher?
Intuitive Surgical (ISRG) shares fell 10.4% in the past year, while the S&P 500 returned 16.5%. Much of the market has focused on moderating U.S. procedure growth. The more telling number is 144 trade-ins in fiscal Q2 2026, up from 83 a year earlier. Most came from customers moving to the new da Vinci 5 robot. Those trade-ins matter most if upgrades continue and each surgery also earns more. Is that number a blip, or are customers still trading up.
Smoke Evacuation Systems Market Forecasts Growth from $0.20B (2025) to $0.30B by 2031, Profiling CONMED, Medtronic, Stryker & Becton Dickinson
The global smoke evacuation systems market is forecast to grow from USD 0.20 billion in 2025 to USD 0.30 billion by 2031, at a 7.5% CAGR. Growth is driven by rising minimally invasive, electrosurgical and laparoscopic procedures, stricter surgical smoke safety guidance, and demand for better operating room air quality. Smoke evacuation pencils and wands lead the product segment, while laparoscopic surgery holds the largest application share. The US is expected to record North America’s fastest g
Medical Robots Market Forecasts Growth from $20.6B (2026) to $41.7B by 2031, Profiling Intuitive Surgical, Stryker, Zimmer Biomet & Medtronic
The global medical robots market is projected to grow from USD 20.6 billion in 2026 to USD 41.7 billion by 2031, at a 15.1% CAGR. Growth is driven by demand for minimally invasive surgery, healthcare automation, precision procedures, and advances in AI-powered surgical, rehabilitation, radiosurgery, hospital, and pharmacy robots. Robotic systems will hold the largest market share, while surgical robots will lead by type. Ambulatory surgery centers are set for the fastest end-user growth, and Asi
Temperature Management Systems Market Forecasts Growth from $3.56B (2026) to $4.58B by 2031, Profiling 3M, Asahi-Kasei, GE Healthcare, Dragerwerk & Medtronic
The global temperature management systems market is projected to grow from USD 3.56 billion in 2026 to USD 4.58 billion by 2031, at a 5.2% CAGR. Growth is driven by rising surgical volumes, cardiovascular and neurological disorders, perioperative hypothermia prevention, and targeted temperature management in critical care. Patient warming systems and perioperative care led in 2025, while Asia Pacific is expected to grow fastest. Key players include Solventum, GE HealthCare, Dräger, Ecolab, Medtr
What Does General Dynamics (GD) Winning New Stryker Work Mean Through 2028?
General Dynamics (NYSE:GD) received a new multi year U.S. Army contract modification for Double V Hull A1 Stryker vehicles, extending through 2028. The award enlarges the Army Stryker program backlog and adds funded production for upgraded armored vehicles across multiple brigade combat teams. The contract update supports continued manufacturing at General Dynamics Land Systems facilities that produce Stryker chassis and mission packages. The extra Double V Hull A1 Stryker work is...
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now?
ISRG's rapid procedure growth, expanding robotics ecosystem and recurring revenues highlight its growth path amid MedTech shifts.
Can Stryker Vehicle Demand Support General Dynamics' Growth?
GD's Stryker contract modification lifts cumulative value to $278.9M, supporting Land Systems demand through December 2028.
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
SYK's resilient demand, Mako robotics growth and margin gains support its outlook despite cyber and supply disruptions.
Surgical Devices Market Size to Worth USD 27.14 Billion by 2030, at a CAGR of 14.7% – MarketsandMarkets™
Delray Beach, FL, Sept. 23, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global surgical devices market will grow from USD 188.74 billion in 2026 to USD 296.76 billion by 2031, at a CAGR of 9.5% during the forecast period. Market growth is driven by the increasing aging population, rising surgical procedures, adoption of minimally invasive and robotic surgeries, technological advancements, and expanding healthcare infrastructure globally. Get PDF Brochure - Market Data & Segmentation
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now
Players: Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker, Zimmer Biomet. Profile covers competitors, segments, regional shares, trends and opportunities. Minimally Invasive Robotic Surgical System Market Minimally Invasive Robotic Surgical System Market Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Minimally Invasive Robotic Surgical System Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. Minimally Invasive Robotic Surgical System Market to Reach $18.15 Bil
Stryker (SYK) Foot And Ankle Push Keeps Undervalued Narrative In Focus
Why Stryker’s new Foot & Ankle push matters for shareholders Stryker (SYK) is putting fresh attention on its Foot & Ankle franchise, rolling out new planning tools and limb reconstruction hardware at the 2026 AOFAS meeting in Seattle. The spotlight is on Prophecy Surgical Planning, now linked to the Incompass Total Ankle System, and on the Hoffmann LRF smartHEX platform, which extends the company’s reach into complex deformity correction supported by mobile software. Set against this product...
THINK Surgical Appoints Rick McDowell as Vice President, Sales
THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced that Rick McDowell has joined the company as Vice President, Sales. In this role, Rick will report to Chris Marrus, Executive Vice President, and will lead THINK Surgical's national sales organization, driving market strategy and growth as the company continues to scale its commercial operations.
How Far Can BSX Stock Swing After Losing More Than Half Its Value?
Boston Scientific (BSX) stock has fallen 55.5% over the past twelve months, and at $43.72 it trades barely above its 52-week low of $42.63. The options market now prices a likely one-year range from $28.46 to $67.16 a share. That band is wide, but it is close to how much the stock has already been moving.
TD Cowen Maintains Hold on Stryker, Lowers Price Target to $298
TD Cowen analyst Mathew Blackman maintains Stryker (NYSE:SYK) with a Hold and lowers the price target from $355 to $298.
Stryker (SYK) Expanded Its Foot And Ankle Portfolio
Stryker (NYSE:SYK) announced new Foot & Ankle portfolio updates, including expanded Prophecy Surgical Planning, at a major industry meeting. The company introduced the Hoffmann LRF smartHEX system, aimed at limb reconstruction and patient connectivity in complex cases. Expanded planning tools and patient specific technologies are intended to support surgeon decision making in ankle replacement procedures. The Prophecy Surgical Planning expansion and Hoffmann LRF smartHEX launch sit alongside...
3 Defensive Dividend Stocks For Steady Income as Fed Pressure Builds
Markets are wrestling with a Fed that sounds more willing to tolerate economic pain than investors expected, while supply shocks from oil and tariffs keep pressure on costs. That mix tends to push attention toward reliable cash flows and dividends, as many traders reassess how much risk they really want to hold. This article walks through three large-cap, income-focused stocks exposed to this macro backdrop and explains how each may factor into your portfolio decisions now. The stocks below...
Ambulatory Surgery Centers Are Becoming ISRG's New Growth Engine
Intuitive Surgical is expanding robotic surgery in ASCs with lower-cost XiR systems, opening access to new customers and outpatient procedures.
How Far Could ISRG Stock Bounce From Here?
Intuitive Surgical (ISRG) stock could climb 23.9% to the April high it last fell back from, and you would risk about 5% to find out. That looks like a surgical-robot leader on sale, but the price history disagrees. Over the last two years, none of its visits to this price range turned into a 20% gain before a 5% drop.
Treace Medical Looks Unlikely To Recover, A Founder-Led Broken Growth Story
Treace Medical outlook: revenue declines, Lapiplasty losing share, margins compressing, and EBITDA delayed. Click for more on TMCI stock.
3 of Wall Street’s Favorite Stocks Worth Investigating
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Can Intuitive Surgical Make Up For A Lower Price Per Surgery?
Intuitive Surgical (ISRG) has lost about 12% over the past year, while the S&P 500 returned about 17%. Most of the debate has been about the U.S. procedure growth slowing. The number that should worry a holder more is the money the company collects on the instruments used in each operation. Intuitive plans to lower it.
Canaccord Genuity Maintains Buy on Stryker, Lowers Price Target to $385
Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $400 to $385.
Is ISRG Stock Really As Expensive As It Looks?
Intuitive Surgical (ISRG), maker of the da Vinci surgical robots, trades at about $382, some 36% below its 52-week high. Even so, you pay about 35.9 times trailing adjusted earnings. That is normalized net income with stock-based compensation added back, a basis meant to sit closer to the one analysts forecast on, though the two are not defined identically. Analysts' forecasts run to 2027, the year Intuitive plans to start lowering what customers pay per use on some instruments.
Why BSX Stock Lost More Than Half Its Value While Sales Kept Rising
Boston Scientific (BSX) has fallen about 54% since late December 2025, and it now sits at $43.91, just above a 52-week low of $42.63. Device peers were mixed over the same nine months: Abbott lost about 17%, Medtronic barely moved, and Johnson & Johnson rose about 32%. The market repriced Boston Scientific's growth rate after management concentrated its guidance cut in two core product lines.
Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says
Stryker (SYK) will likely see an acceleration story in 2027, with high single digit growth achievabl
Stryker Expands Foot & Ankle Innovation With Prophecy and smartHEX
SYK expands its Foot & Ankle portfolio with Prophecy for Incompass and smartHEX, linking planning, implants and limb reconstruction.
GEHC or SYK: Which Is the Better Value Stock Right Now?
GEHC vs. SYK: Which Stock Is the Better Value Option?
Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™
Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it will showcase new advancements across its Foot & Ankle portfolio at the 2026 American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Seattle, including the launch of Prophecy Surgical Planning for the Incompass Total Ankle System and the introduction of Hoffmann LRF smartHEX.
Stryker (NYSE:SYK): A Dividend Quality Pick for Income Investors
Stryker stock: 1.02% yield, 7/10 dividend rating, 35% payout ratio and 10+ years without a cut. A quality dividend pick for steady income growth.
Baron Health Care Fund Q2 2026 Portfolio Activity
During the quarter, we added 8 new positions and exited 6 positions, bringing the number of positions in the Fund to 43.
2 Healthcare Stocks to Research Further and 1 We Find Risky
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 31.6% over the past six months, topping the S&P 500 by 17.9 percentage points.
Has BSX Stock Finally Hit Bottom?
Boston Scientific (BSX) stock has fallen about 57% over the past year, to about $45. The shares now sell for 3.2 times trailing sales, hovering near their decade-long historical trough of roughly 3.0 times and well off their 8.6 high.
Stryker (SYK) Stock Still Looks Cheap On Its 24% Slide
Stryker has seen its share price slide sharply over the past year, and the question now is whether the current valuation still lines up with the cash the business is expected to generate. For investors watching the stock after recent headlines, the focus has shifted from past returns to whether today's price fairly reflects those underlying cash flows. The stock has fallen 24.5% over the past year, which puts the spotlight on whether that move has brought the valuation closer to what its...
Why Pay More For Stryker When BSX Stock Is On Sale?
A medical device giant now costs more than its faster-growing rivals, forcing investors to decide if its premium price tag is buying durable quality or just yesterday's story.
Boston Scientific Leans on Acquisitions to Drive Long-Term Growth
BSX's deal-making push expands its reach into high-growth markets, with Penumbra adding a major thrombectomy opportunity.
Get Paid To Wait For ISRG Stock To Go On Sale
Intuitive Surgical (ISRG) trades near $370, about 38% below its 52-week high, after growth in its US robotic-surgery procedures slowed. Selling a put pays you now for agreeing to buy the shares much lower, and you keep the payment either way. The catch is it only works if you would want this business at that price.
Stryker: Operational Issues Have Created An Opportunity
Stryker's share price declined significantly due to operational issues, valuation concerns, and weaker orthopedic procedure volume growth. Learn more about SYK stock here.
Dexcom Appoints Glenn Boehnlein to Board of Directors
SAN DIEGO, September 10, 2026--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026.
Citigroup Maintains Buy on Stryker, Lowers Price Target to $360
Citigroup analyst Joanne Wuensch maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $399 to $360.
Stryker stock falls on slower peripheral vascular, hip sales
CFO Preston Wells said at a healthcare conference that the company is still working through supply issues in its peripheral vascular business and had fewer hip sales than expected so far this quarter.
How Much Can ISRG Stock Still Move Against You?
Intuitive Surgical (ISRG) has handed its owners a hard year. The stock is down 25% over the trailing twelve months while the S&P 500 returned 19.3%, and it now trades about 41% below its 52-week high. After a fall like that the natural hope is that the big moves are behind you. Options priced a year out say they are not.
BSX Stock: Is It Time To Buy Or Sell Puts?
Trading near $45 a share, Boston Scientific (BSX) sits roughly 58% below its 52-week peak. Instead of buying the dip outright, selling cash-secured put options allows investors to generate immediate income while locking in an even deeper entry point. Sell a put option on BSX expiring 9/17/2027, with a strike price of $30.
Pulmera Appoints Jared Slibeck Chief Commercial Officer
Twenty-year industry veteran in surgical navigation and enabling technology joins Pulmera to spearhead commercial adoption of its CBeam™ 3D Imaging Platform, the first C-Arm Native 3D imaging system. 20-Year Stryker Veteran Jared Slibeck Joins Pulmera as Chief Commercial Officer Jared Slibeck has been named Chief Commercial Officer for Pulmera, effective September 1, 2026. Slibeck will lead the company’s commercial strategy and market development as the company brings the CBeam™ 3D Imaging Platf
ISRG Stock Trading at its Cheapest in 10 Years: Should You Buy Now?
Intuitive Surgical trades at its cheapest valuation in 10 years as strong growth, innovation and procedure gains face rising costs and market pressures.
Wells Fargo Maintains Overweight on Stryker, Lowers Price Target to $348
Wells Fargo analyst Larry Biegelsen maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $418 to $348.
Uncover the latest developments among S&P500 stocks in today's session.
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Tuesday. Stay informed about the market activity below.
These S&P500 stocks are moving in today's session
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
Supply chain woes send Stryker stock tumbling 7.7%
Investing.com -- Stryker Corp. shares dropped as much as 7.7% on Tuesday morning after company executives discussed ongoing problems in its peripheral vascular and joint replacement operations at an industry conference.
Stryker Corporation (SYK) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Stryker Corporation (SYK) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 10:15 AM EDTCompany ParticipantsPreston Wells - VP &...
S&P 500, Nasdaq Slip as $98 Brent Reignites Inflation Fears: Stock Market Today
Crude near $98 pushes the 10-year Treasury yield above 4.8% for the first time since 2023, hammering the Dow as traders price a Fed rate hike next week.
Stocks making the biggest moves midday: Amgen, Qualcomm, Expedia, CoreWeave & more
Here are some of the companies making headlines in midday trading.
Global Surgical Robots Market to Reach $10.6 Billion in 2026, Driven by AI Integration and Minimally Invasive Surgery
Report Features In-Depth Profiles of Abbott, Great Robotics, Intuitive Surgical, Johnson & Johnson, Medtronic, Panasonic, Renishaw, Siemens Healthineers, Smith+Nephew, Stryker, Zimmer Biomet, and FreehandDublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Surgical Robots Market by Offering of Surgical Robot Developers, Deployment Model, Type of Surgical Procedure Supported, Application Area, End Users and Key Geographical Regions - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.
Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference
Portage, Michigan, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor, as previously reported. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will now participate in a fireside chat session at 10:15 a.m. (Eastern time). A simultaneous live audio webcast and replay of the session can be accessed at Stryker - Events &
Stryker (SYK) is Buying ZuriMED. Can FiberLocker Strengthen its Shoulder Portfolio?
Stryker Corporation (NYSE:SYK) signed a definitive agreement to acquire privately held ZuriMED, which would add the commercialized FiberLocker System to its shoulder portfolio upon closing. FiberLocker is designed to reinforce rotator-cuff repairs by strengthening the connection between a surgical patch and tendon tissue. The transaction remains subject to customary closing conditions, while the purchase price […]
How Much Upside Can BSX Stock's Growth Deliver?
While two high-profile segments - WATCHMAN and Electrophysiology - have stumbled, the market is overlooking the company's core stability. Business units representing roughly 75% of revenue are performing consistently with their historical track record, though this durable base's near-term ~6% growth leaves our 10.8% three-year CAGR reliant on a post-2026 pipeline re-acceleration.
Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money
Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference buried inside their business models quietly separates a compounder from a cyclical recovery story.
Boston Scientific's ICVT Business Gains Momentum: Can Growth Continue?
BSX's ICVT sales have jumped 15% as coronary therapies gained traction, while new devices and deals could extend its growth momentum.
Stryker Launches FDA-Cleared Apple Vision Pro Surgical App
SYK's FDA-cleared SportSuite Vision brings Apple Vision Pro into hip arthroscopy, strengthening its digital surgery push and Sports Medicine portfolio.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-24 | Wells Preston Wendell | -109 | - | - |
| 2026-09-22 | Wells Preston Wendell | -962 | - | - |
| 2026-08-21 | Crotty Dylan Bram | -441 | $328.605 | $144,915 |
| 2026-08-19 | STRYKER RONDA E | -805 | $343.472 | $276,495 |
| 2026-08-19 | STRYKER RONDA E | -3,852 | $342.797 | $1,320,454 |
| 2026-08-19 | STRYKER RONDA E | -3,274 | $341.839 | $1,119,181 |
| 2026-08-19 | STRYKER RONDA E | -16,612 | $340.706 | $5,659,808 |
| 2026-08-19 | STRYKER RONDA E | -10,812 | $339.71 | $3,672,945 |
| 2026-08-19 | STRYKER RONDA E | -11,257 | $338.899 | $3,814,986 |
| 2026-08-19 | STRYKER RONDA E | -2,308 | $337.982 | $780,062 |
| 2026-08-19 | STRYKER RONDA E | -320 | $336.793 | $107,774 |
| 2026-08-19 | STRYKER RONDA E | -80 | $335.055 | $26,804 |
| 2026-08-19 | STRYKER RONDA E | -200 | $333.931 | $66,786 |
| 2026-08-19 | STRYKER RONDA E | -440 | $333.177 | $146,598 |
| 2026-08-19 | STRYKER RONDA E | -40 | $331.805 | $13,272 |
| 2026-08-18 | King Debra | -826 | $336.304 | $277,787 |
| 2026-08-18 | STRYKER RONDA E | -3,481 | $338.498 | $1,178,312 |
| 2026-08-18 | STRYKER RONDA E | -16,243 | $337.629 | $5,484,108 |
| 2026-08-18 | STRYKER RONDA E | -109,425 | $336.433 | $36,814,181 |
| 2026-08-18 | STRYKER RONDA E | -131,752 | $335.642 | $44,221,505 |
| 2026-08-18 | STRYKER RONDA E | -25,536 | $334.945 | $8,553,156 |
| 2026-08-18 | STRYKER RONDA E | -8,404 | $333.825 | $2,805,465 |
| 2026-08-18 | STRYKER RONDA E | -2,920 | $332.694 | $971,466 |
| 2026-08-18 | STRYKER RONDA E | -2,239 | $331.742 | $742,770 |
| 2026-08-01 | Montagnino Kimberly Ann | -155 | $325.7 | $50,484 |
| 2026-08-01 | King Debra | -533 | $325.7 | $173,598 |
| 2026-08-01 | Fletcher Robert S | -94 | $325.7 | $30,616 |
| 2026-08-01 | Fink M Kathryn | -111 | $325.7 | $36,153 |
| 2026-07-17 | Wells Preston Wendell | -1,777 | - | - |
| 2026-06-01 | Stiles Spencer S | -1,607 | - | - |
| 2026-05-28 | Fletcher Robert S | -125 | $310.22 | $38,778 |
| 2026-05-28 | Fletcher Robert S | -258 | $308.785 | $79,667 |
| 2026-05-28 | Fletcher Robert S | -1,067 | $307.297 | $327,886 |
| 2026-05-28 | Fletcher Robert S | -2,809 | $306.564 | $861,138 |
| 2026-05-28 | Fletcher Robert S | -165 | $305.66 | $50,434 |
| 2026-05-28 | Fletcher Robert S | -120 | $304.225 | $36,507 |
| 2026-05-26 | STRYKER RONDA E | -3,707 | $315.114 | $1,168,128 |
| 2026-05-26 | STRYKER RONDA E | -10,407 | $314.375 | $3,271,701 |
| 2026-05-26 | STRYKER RONDA E | -44,060 | $313.349 | $13,806,157 |
| 2026-05-26 | STRYKER RONDA E | -114,059 | $312.444 | $35,637,050 |
| 2026-05-26 | STRYKER RONDA E | -115,960 | $311.596 | $36,132,672 |
| 2026-05-26 | STRYKER RONDA E | -21,807 | $310.77 | $6,776,961 |
| 2026-05-11 | Fink M Kathryn | -3,500 | $283.453 | $992,085 |
| 2026-05-11 | Fink M Kathryn | -5,220 | $283.845 | $1,481,671 |
| 2026-05-08 | Fink M Kathryn | -11,850 | - | - |
| 2026-05-08 | Fink M Kathryn | -9,732 | - | - |
| 2026-05-08 | Fink M Kathryn | -16,362 | $294.23 | $4,814,191 |
| 2026-05-08 | Fink M Kathryn | +11,850 | $179.35 | $2,125,298 |
| 2026-05-08 | Fink M Kathryn | +9,732 | $154.14 | $1,500,090 |
| 2026-05-06 | Skeete Tatum Lisa M | +762 | - | - |
| 2026-05-06 | BRAINERD MARY K | +762 | - | - |
| 2026-05-06 | Montagnino Kimberly Ann | +677 | - | - |
| 2026-05-06 | King Debra | +1,016 | - | - |
| 2026-05-06 | Ruggeri Rachel | +762 | - | - |
| 2026-05-06 | Suri Rajeev | +762 | - | - |
| 2026-05-06 | Caforio Giovanni | +762 | - | - |
| 2026-05-06 | Silvernail Andrew K | +762 | - | - |
| 2026-05-06 | McCoy Sherilyn S | +762 | - | - |
| 2026-05-06 | STRYKER RONDA E | +762 | - | - |
| 2026-03-21 | Crotty Dylan Bram | -368 | $335.67 | $123,527 |
| 2026-03-21 | Wells Preston Wendell | -204 | $335.67 | $68,477 |
| 2026-03-21 | Pierce James Andrew | -430 | - | - |
| 2026-03-21 | Pierce James Andrew | -7,807 | $335.67 | $2,620,576 |
| 2026-03-21 | Pierce James Andrew | +430 | - | - |
| 2026-03-21 | Stiles Spencer S | -430 | - | - |
| 2026-03-21 | Stiles Spencer S | -6,690 | $335.67 | $2,245,632 |
| 2026-03-21 | Stiles Spencer S | +430 | - | - |
| 2026-03-21 | Fletcher Robert S | -225 | - | - |
| 2026-03-21 | Fletcher Robert S | -3,384 | $335.67 | $1,135,907 |
| 2026-03-21 | Fletcher Robert S | +225 | - | - |
| 2026-03-21 | Menon Viju | -269 | - | - |
| 2026-03-21 | Menon Viju | -4,718 | $335.67 | $1,583,691 |
| 2026-03-21 | Menon Viju | +269 | - | - |
| 2026-03-21 | Fink M Kathryn | -150 | - | - |
| 2026-03-21 | Fink M Kathryn | -2,064 | $335.67 | $692,823 |
| 2026-03-21 | Fink M Kathryn | +150 | - | - |
| 2026-03-21 | Berry William E Jr | -176 | $335.67 | $59,078 |
| 2026-03-21 | Lobo Kevin | -1,452 | - | - |
| 2026-03-21 | Lobo Kevin | -26,492 | $335.67 | $8,892,570 |
| 2026-03-21 | Lobo Kevin | +1,452 | - | - |
| 2026-03-09 | Pierce James Andrew | +14,912 | - | - |
| 2026-03-09 | Stiles Spencer S | +14,912 | - | - |
| 2026-03-09 | Fletcher Robert S | +7,828 | - | - |
| 2026-03-09 | Menon Viju | +9,320 | - | - |
| 2026-03-09 | Fink M Kathryn | +5,220 | - | - |
| 2026-03-09 | Lobo Kevin | +50,332 | - | - |
| 2026-02-23 | STRYKER RONDA E | -55,600 | - | - |
| 2026-02-17 | STRYKER RONDA E | -42,000 | - | - |
| 2026-02-17 | STRYKER RONDA E | -222,300 | - | - |
| 2026-02-13 | STRYKER RONDA E | -377,900 | - | - |
| 2026-02-06 | Lobo Kevin | -206,955 | - | - |
| 2026-02-06 | Lobo Kevin | -132,410 | $362.42 | $47,988,032 |
| 2026-02-06 | Lobo Kevin | +206,955 | $96.64 | $20,000,131 |
| 2026-02-05 | STRYKER RONDA E | -6,342 | $366.985 | $2,327,419 |
| 2026-02-05 | STRYKER RONDA E | -23,151 | $366.35 | $8,481,369 |
| 2026-02-05 | STRYKER RONDA E | -51,774 | $365.257 | $18,910,816 |
| 2026-02-05 | STRYKER RONDA E | -34,607 | $364.285 | $12,606,811 |
| 2026-02-05 | STRYKER RONDA E | -61,199 | $363.341 | $22,236,106 |
| 2026-02-05 | STRYKER RONDA E | -68,688 | $362.416 | $24,893,630 |
| 2026-02-05 | STRYKER RONDA E | -4,239 | $361.495 | $1,532,377 |
| 2026-02-04 | Crotty Dylan Bram | +9,978 | - | - |
| 2026-02-04 | Montagnino Kimberly Ann | +1,830 | - | - |
| 2026-02-04 | Wells Preston Wendell | +11,974 | - | - |
| 2026-02-04 | King Debra | +3,992 | - | - |
| 2026-02-04 | Pierce James Andrew | +15,300 | - | - |
| 2026-02-04 | Pierce James Andrew | +2,771 | - | - |
| 2026-02-04 | Stiles Spencer S | +19,956 | - | - |
| 2026-02-04 | Fletcher Robert S | +8,980 | - | - |
| 2026-02-04 | Menon Viju | +10,310 | - | - |
| 2026-02-04 | Fink M Kathryn | +5,654 | - | - |
| 2026-02-04 | Berry William E Jr | +2,391 | - | - |
| 2026-02-04 | Berry William E Jr | +797 | - | - |
| 2026-02-04 | Lobo Kevin | +58,206 | - | - |
| 2026-02-04 | STRYKER RONDA E | -2,160 | $368.556 | $796,081 |
| 2026-02-04 | STRYKER RONDA E | -6,783 | $367.91 | $2,495,534 |
| 2026-02-04 | STRYKER RONDA E | -4,836 | $366.563 | $1,772,699 |
| 2026-02-04 | STRYKER RONDA E | -29,110 | $365.571 | $10,641,772 |
| 2026-02-04 | STRYKER RONDA E | -61,956 | $364.681 | $22,594,176 |
| 2026-02-04 | STRYKER RONDA E | -20,395 | $363.496 | $7,413,501 |
| 2026-02-04 | STRYKER RONDA E | -30,067 | $362.689 | $10,904,970 |
| 2026-02-04 | STRYKER RONDA E | -25,220 | $361.385 | $9,114,130 |
| 2026-02-04 | STRYKER RONDA E | -40,363 | $360.414 | $14,547,390 |
| 2026-02-04 | STRYKER RONDA E | -14,673 | $359.483 | $5,274,694 |
| 2026-02-04 | STRYKER RONDA E | -14,437 | $358.509 | $5,175,794 |
| 2026-02-03 | Stiles Spencer S | -13,840 | - | - |
| 2026-02-03 | Stiles Spencer S | -7,692 | $368.14 | $2,831,733 |
| 2026-02-03 | Stiles Spencer S | +13,840 | $96.64 | $1,337,498 |
| 2026-02-02 | Pierce James Andrew | -13,840 | - | - |
| 2026-02-02 | Pierce James Andrew | -475 | $368.873 | $175,215 |
| 2026-02-02 | Pierce James Andrew | -8,432 | $369.56 | $3,116,130 |
| 2026-02-02 | Pierce James Andrew | +13,840 | $96.64 | $1,337,498 |
| 2026-01-15 | Silvernail Andrew K | -4,570 | - | - |
| 2026-01-15 | Silvernail Andrew K | -1,229 | $359.39 | $441,690 |
| 2026-01-15 | Silvernail Andrew K | +4,570 | $96.64 | $441,645 |
| 2026-01-14 | STRYKER RONDA E | -4,570 | - | - |
| 2026-01-14 | STRYKER RONDA E | +4,570 | $96.64 | $441,645 |
| 2025-12-16 | Fink M Kathryn | -37 | $355.31 | $13,146 |
| 2025-12-16 | Berry William E Jr | -28 | $355.31 | $9,949 |
| 2025-11-21 | Pierce James Andrew | +106 | - | - |
| 2025-11-21 | Pierce James Andrew | +105 | - | - |
| 2025-11-21 | Pierce James Andrew | -211 | - | - |
| 2025-11-20 | Wells Preston Wendell | -165 | $365.88 | $60,370 |
| 2025-11-14 | Berry William E Jr | -4,925 | - | - |
| 2025-11-14 | Berry William E Jr | -1,953 | $365.49 | $713,802 |
| 2025-11-14 | Berry William E Jr | -2,972 | $373.42 | $1,109,804 |
| 2025-11-14 | Berry William E Jr | +4,925 | $154.14 | $759,139 |
| 2025-11-06 | STRYKER RONDA E | -1,754 | $355.8 | $624,073 |
| 2025-11-06 | STRYKER RONDA E | -24,654 | $355.1 | $8,754,635 |
| 2025-11-06 | STRYKER RONDA E | -36,390 | $354.13 | $12,886,791 |
| 2025-11-06 | STRYKER RONDA E | -141,052 | $353.17 | $49,815,335 |
| 2025-11-06 | STRYKER RONDA E | -68,108 | $352.45 | $24,004,665 |
| 2025-11-06 | STRYKER RONDA E | -3,819 | $351.3 | $1,341,615 |
| 2025-11-06 | STRYKER RONDA E | -396 | $349.95 | $138,580 |
| 2025-11-05 | STRYKER RONDA E | -180 | $359.79 | $64,762 |
| 2025-11-05 | STRYKER RONDA E | -31,809 | $358.68 | $11,409,252 |
| 2025-11-05 | STRYKER RONDA E | -72,208 | $357.89 | $25,842,521 |
| 2025-11-05 | STRYKER RONDA E | -67,906 | $357.06 | $24,246,516 |
| 2025-11-05 | STRYKER RONDA E | -29,391 | $356.16 | $10,467,899 |
| 2025-11-05 | STRYKER RONDA E | -22,360 | $354.94 | $7,936,458 |
| 2025-11-05 | STRYKER RONDA E | -19,973 | $354.13 | $7,073,038 |
| 2025-11-01 | Wells Preston Wendell | -404 | $356.24 | $143,921 |